ORDRCC

Welcome
Leadership
Administrative Core
Cores
Investigator Support
For Patients
- Get Involved
- Getting to the Clinic
Discoveries

What we're about

Advancing prediction, prevention, and precision therapy for patients with rheumatic diseases
Who we are

Over 200 researchers spanning the basic, clinical, and analytical sciences
How we help

World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careers
Why we care

Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives

shutterstock_211939057

shutterstock_347560208

b2jyXojmp3qjCvjQxTK50QRmNNc2VNzkte8d3Oq2JOoRTKHVnmKyhHJawEB5A_QVtWgYzBFMgTvdcIe20Mtw0Q-1024×681

DrMerrill_patientstudiesphoto-1024×569

Extensive Cohort Collections

Our CAP-accredited biorepository manages some of the largest existing collections of SLE, Sjogren’s, RA, and osteoarthritis samples

Cutting Edge Methodologies

The Human Phenotyping Core offers single-cell technologies, including CyTOF, Spatial Transcriptomics, and scRNASeq

Clinical Research Expertise

A physician examines a patient's hand in an exam room — The Clinical Core assists with IRB approvals, study recruitment, and clinical research visits

Recent Publications

Genetic load in incomplete lupus erythematosus January 4, 2023
Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses December 1, 2022
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus October 17, 2022
The promise of precision medicine in rheumatology July 5, 2022
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals June 20, 2022
Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus June 20, 2022
47XXY and 47XXX in Scleroderma and Myositis March 30, 2022

Cite ORDRCC Support
Publications that used ORDRCC consultations, services, or resources should cite P30AR073750.

Oklahoma Rheumatic Disease Research Cores Center

At the Oklahoma Medical Research Foundation in Oklahoma City, OK

Copyright © 2017 Oklahoma Medical Research Foundation Login

Welcome
Leadership
Administrative Core
Cores
Investigator Support
For Patients
- Get Involved
- Getting to the Clinic
Discoveries